Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency.

European journal of pediatrics - 1 Dec 2014

Butwicka Agnieszka, Krystyna Szymańska, Retka Włodzimierz, Wolańczyk Tomasz

Abstract excerpt

We describe a patient with dystonia and psychotic symptoms treated with standard doses of antipsychotics, who developed neuroleptic malignant syndrome (NMS). A 16-year-old male with a history of misuse of dextromethorphan and pseudoephedrine for recreational purpose presented with dystonia and a psychotic episode. Following continuous treatment with olanzapine (10 mg/day), repeated injections of levomepromazine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genetic Testing

Share to Homozygote

Share to Real-Time Polymerase Chain Reaction

Share to Time Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 24253372
DOI: 10.1007/s00431-013-2208-z
PMCID: PMC4245487

Genes

NMS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency.PMID 24253372Read ↗

The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.Semantic proximity Read ↗

Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case reportSemantic proximity Read ↗

A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.Semantic proximity Read ↗

Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients.Semantic proximity Read ↗

Genetic predisposition to neuroleptic malignant syndrome : implications for antipsychotic therapy.Semantic proximity Read ↗

Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.Semantic proximity Read ↗

Clinical implications of CYP2D6 genetic polymorphism during treatment with antipsychotic drugs.Semantic proximity Read ↗

Monogenic Syndromes as a Cause of Adverse Drug Reactions in the Russian PopulationSemantic proximity Read ↗

CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.Semantic proximity Read ↗

Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study.Semantic proximity Read ↗

Psychiatric Disorder or Adverse Drug Reaction? - How CYP2D6 Metabolizing Activity Can Result in Dextromethorphan Intoxication.Semantic proximity Read ↗

Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.